<SEC-DOCUMENT>0000917520-25-000100.txt : 20251212
<SEC-HEADER>0000917520-25-000100.hdr.sgml : 20251212
<ACCEPTANCE-DATETIME>20251212163113
ACCESSION NUMBER:		0000917520-25-000100
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20251211
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251212
DATE AS OF CHANGE:		20251212

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		251568588

	BUSINESS ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>iart-20251211.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:019b0429-3cd9-7863-984f-7f8fca2cf9a4,g:a9d7697a-a4c4-4f6e-a467-2e81f3a981f3,d:e1fc82fd19cf4379b01323b5ef4b170c-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iart-20251211</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000917520</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iart-20251211.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-12-11</xbrli:startDate><xbrli:endDate>2025-12-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie1fc82fd19cf4379b01323b5ef4b170c_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:13.5pt;font-weight:400;line-height:120%">Washington, D.C. 20549 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">December 11, 2025</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">INTEGRA LIFESCIENCES HOLDINGS CORP</ix:nonNumeric>ORATION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter) </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.023%"><tr><td style="width:1.0%"/><td style="width:40.015%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.686%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">0-26224</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">51-0317849</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of  Incorporation or Organization) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1100 Campus Road</ix:nonNumeric>  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Princeton</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">NJ</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">08540</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">609</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">275-0500</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report) </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR   240.14d-2(b)).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).</span></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">Securities Registered Pursuant to Section12(b) of the Act:</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.793%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.954%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, Par Value $.01 Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">IART</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie1fc82fd19cf4379b01323b5ef4b170c_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">On December 11, 2025, Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) adopted a change in control severance program (the &#8220;Program&#8221;) under which certain executives of the Company, including Lea Knight, Executive Vice President and Chief Financial Officer, Robert T. Davis, Jr., Executive Vice President, President &#8211; Tissue Technologies, Michael McBreen, Executive Vice President, President &#8211; Codman Specialty Surgical, and Harvinder Singh, Executive Vice President, President &#8211; International, are participants (each, an &#8220;executive participant&#8221;). The Program is effective as of January 1, 2026, and renews the Program for executive participants scheduled to expire on December 31, 2025.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The Program provides for the payment of severance and other benefits to the executive participants in the event of a &#8220;qualifying termination,&#8221; which means a termination of employment with the Company without &#8220;cause&#8221; or by the executive participant for &#8220;good reason,&#8221; in either case, on or within two years following a &#8220;change in control&#8221; of the Company and so long as such change in control occurs by December 31, 2026 (each, as defined in the Program). In the event of a qualifying termination, the Program provides for:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">a lump sum payment equal to 1.5 times (or 2 times for Ms. Knight) the sum of the executive participant&#8217;s annual base salary and target cash bonus;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">a lump sum payment equal to a pro rata portion of the executive participant&#8217;s target cash bonus for the partial fiscal year in which the termination occurs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Company-subsidized COBRA premium payments for up to eighteen months following the termination date;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Company-paid outplacement services for up to twelve months following the termination date; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">to the extent the executive participant has not yet received his or her short-term annual cash bonus for prior-year performance with the Company, the executive participant shall still receive such short-term annual cash bonus for prior-year performance at the time non-terminated employees receive such short-term annual cash bonus if such payment is due.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">An executive participant&#8217;s right to receive the severance payments and benefits described above is subject to the delivery and non-revocation of an effective general release of claims in favor of the Company.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">In addition, under the Program, to the extent that any change in control payment or benefit would be subject to an excise tax imposed in connection with Section 4999 of the Internal Revenue Code, such payments and/or benefits may be subject to a &#8220;best pay cap&#8221; reduction to the extent necessary so that the executive participant receives the greater of the (i) net amount of the change in control payments and benefits reduced such that such payments and benefits will not be subject to the excise tax and (ii) net amount of the change in control payments and benefits without such reduction.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The term of the Program expires on December 31, 2026, and any extension of the term requires the approval of the Compensation Committee of the Company&#8217;s Board of Directors. However, upon the occurrence of a change in control, the term will automatically be extended until the two-year anniversary of the date on which the change in control occurs. In addition, if an executive participant incurs a qualifying termination during the term of the Program, the term automatically will be further extended until each party&#8217;s rights and obligations are fully satisfied.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">The foregoing description of the Program is not complete and is subject to and qualified in its entirety by the terms of the Program, a copy of which is filed herewith as Exhibit 10.1 and incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">10.1 </span><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="exhibit101_cic2026.htm">Change in Control Severance Program</a></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">104  Cover Page Interactive Data File (embedded within the inline XRBL document)</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie1fc82fd19cf4379b01323b5ef4b170c_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:  December 12, 2025</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;/s/ Lesha Shinn&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Lesha Shinn</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:279pt;text-indent:-279pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Deputy General Counsel, Corporate</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">and Business Development and Secretary</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101_cic2026.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i723662e7209f48fb849a8f95edc18aeb_42"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CHANGE IN CONTROL SEVERANCE PROGRAM</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">This Change in Control Severance Program (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Program</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is effective as of January 1, 2026 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">This Program is designed to provide selected officers and key employees of Integra LifeSciences Holdings Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) with certain benefits upon a Qualifying Termination in connection with a Change in Control (each as defined below).  The Company believes that it is in the Company&#8217;s best interests to provide the benefits described herein in order to, in the event of a Change in Control, ensure fair treatment of its officers and key employees and provide incentives for their continued service and performance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  For purposes of this Program, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Base Amount</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the greater of the Participant&#8217;s annual base salary (i) at the rate in effect as of immediately prior to the Participant&#8217;s Qualifying Termination and (ii) at the rate in effect immediately prior to the Change in Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) the Participant&#8217;s neglect of duties or responsibilities that the Participant is required to perform for the Company or any willful failure by the Participant to obey a lawful direction of the Board or the Company&#894; (ii) the Participant&#8217;s engaging in any act of dishonesty, fraud, embezzlement, misrepresentation or other act of moral turpitude&#894; (iii) the Participant&#8217;s knowing violation of any federal or state law or regulation applicable to the Company&#8217;s business&#894; (iv) the Participant&#8217;s material breach of any confidentiality, non-compete agreement or invention assignment agreement or any other material agreement between the Participant and the Company&#894; (v) the Participant&#8217;s conviction of, or plea of guilty or nolo contendere to, any felony or crime of moral turpitude, which conviction or plea is materially and demonstrably injurious to the Company or any of its subsidiaries&#894; (vi) failure by the Participant to comply with the Company&#8217;s material written policies or rules&#894; or (vii) the Participant&#8217;s act or omission in the course of the Participant&#8217;s employment that constitutes gross negligence or willful misconduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">An acquisition (other than directly from the Company or as described in Section 1(d)(v) below) of any voting securities of the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Voting Securities</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) by any &#8220;Person&#8221; (as such term is used for purposes of section 13(d) or 14(d) of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;)) immediately after which such Person has &#8220;Beneficial Ownership&#8221; (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifty percent (50%) or more of the combined voting power of all of the then outstanding Voting Securities, other than the Company, any trustee or other fiduciary holding securities under any employee benefit plan of the Company or an affiliate thereof, or any corporation owned by the Company&#894;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the following event shall not constitute an &#8220;acquisition&#8221; by any Person or group for purposes of this subclause (i)&#58; an acquisition of the Company&#8217;s </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">securities by the Company which causes the Company&#8217;s Voting Securities beneficially owned by a Person or group to represent fifty percent (50%) or more of the combined voting power of the Company&#8217;s then outstanding Voting Securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">The individuals who, as of the Effective Date, are members of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Incumbent Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) cease for any reason to constitute at least two-thirds (2&#47;3) of the Board&#894; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, that if the election, or nomination for election by the stockholders, of any new director was approved by a vote of at least two-thirds (2&#47;3) of the members of the Board who constitute Incumbent Board members (either by a specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for director, without written objection to such nomination), such new directors shall for all purposes be considered as members of the Incumbent Board as of the Effective Date, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided further, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, that no individual shall be considered a member of the Incumbent Board if such individual initially assumed office as a result of either an actual or threatened &#8220;Election Contest&#8221; (as described in Rule 14a-11 promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board of Directors (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Proxy Contest</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) including by reason of any agreement intended to avoid or settle any Election Contest or Proxy Contest&#894;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">Consummation by the Company of a reorganization, merger, or consolidation or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of assets or stock of another entity (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Business Combination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), unless immediately following such Business Combination&#58; (A) more than fifty percent (50%) of the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors of (I) the corporation resulting from such Business Combination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Surviving Corporation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), or (II) if applicable, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Parent Corporation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), is represented, directly or indirectly, by Company Voting Securities outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such Company Voting Securities were converted pursuant to such Business Combination)&#894; and (B) at least a majority of the members of the board of directors of the Parent Corporation (or, if there is no Parent Corporation, the Surviving Corporation) were members of the Incumbent Board at the time of the execution of the initial agreement, or the action of the Board, providing for such Business Combination&#894;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company&#894; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">Acceptance by the stockholders of the Company of shares in a share exchange in respect of shares of the Company representing more than fifty percent (50%)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">of the combined voting power of all of the then outstanding Voting Securities, if the stockholders of the Company immediately before such share exchange do not own, directly or indirectly, immediately following such share exchange more than fifty percent (50%) of the combined voting power of the outstanding Voting Securities of the corporation resulting from such share exchange.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Change in Control constitutes a payment event with respect to any amount which provides for the deferral of compensation and is subject to Code Section 409A, the transaction or event described in subsection (i), (ii), (iii), (iv) or (v) with respect to such amount must also constitute a &#8220;change in control event,&#8221; as defined in Treasury Regulation &#167;&#160;1.409A-3(i)(5) to the extent required by Code Section 409A.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 2 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended, and the Treasury Regulations and other interpretive guidance thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Committee</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">&#8221; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">means the Compensation Committee of the Board (including any successor).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, without the express consent of the Participant, the occurrence of any of the following&#58; (i) a material diminution in the Participant&#8217;s authority, duties or responsibilities or the assignment of duties to the Participant that are materially inconsistent with the Participant&#8217;s position with the Company, other than where the Participant retains the same or substantially the same position, authority, duties and responsibilities with respect to the Company&#8217;s business or portion of the combined company consisting of the Company&#8217;s business as were in effect immediately prior to the Change in Control&#894; (ii) a material reduction in the Participant&#8217;s base salary or the Participant&#8217;s annual short-term cash incentive opportunity, provided that it is not a result of an across the board reduction or part of an across the board pay mix change&#894; or (iii) a change in the geographic location at which the Participant must perform services to a location that is more than fifty (50) miles from (x) the location at which the Participant normally performs such services and (y) the location at which the Participant resides as of the Effective Date, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, that the Participant&#8217;s resignation shall only constitute a resignation for Good Reason if (x) the Participant provides the Company with a notice of termination for Good Reason within sixty (60) days after the initial existence of the facts or circumstances constituting Good Reason, (y)&#160;the Company has failed to cure such facts or circumstances within thirty (30) days after receipt of the notice of termination, and (z)&#160;the date of termination occurs no later than ninety (90) days after the initial occurrence of the facts or circumstances constituting Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Program, &#8220;Good Reason&#8221; shall have the meaning set forth above and, for the avoidance of doubt, the foregoing definition shall not apply for purposes of any other agreement between the Company and the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Participant</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an officer or key employee of the Company whom the Committee has determined will participate in this Program. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (i) a termination by the Participant of the Participant&#8217;s employment with the Company for Good Reason, or (ii) a termination by the Company of the Participant&#8217;s employment with the Company without Cause, in either case, on or within two (2) years after the occurrence of a Change in Control and so long as such Change in Control occurs during the Term (as defined below).  Neither a termination of the Participant&#8217;s employment due to disability nor a termination of the Participant&#8217;s employment due to death shall constitute a Qualifying Termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Separation from Service</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a &#8220;separation from service&#8221; with the Company as such term is defined in Treasury Regulation Section 1.409A-1(h) and any successor provision thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Severance Multiple</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means one-and-one-half (1.5), except in the cases of the Chief Operating Officer and the Chief Financial Officer, for whom the Severance Multiple means two (2).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Target Bonus</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Participant&#8217;s target short-term cash incentive for the year in which the Qualifying Termination occurs.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 3 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The term of this Program (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Term</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) shall be for a period beginning on the Effective Date and ending on December 31, 2026&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided that</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, the Committee may extend the Term of the Program for one (1) year periods in its discretion. Notwithstanding the preceding sentence, upon the occurrence of a Change in Control during the Term, the Term shall automatically be extended until the two (2) year anniversary of the date on which the Change in Control occurs, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">that if the Participant incurs a Qualifying Termination during the Term of this Program, the Term shall be further automatically extended for such additional period as necessary to provide that each party&#8217;s rights and obligations are fully satisfied hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Obligations of the Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">If the Participant has a Qualifying Termination, the Participant shall be entitled to receive the Participant&#8217;s fully earned but unpaid base salary, through the date of the Participant&#8217;s Qualifying Termination at the rate then in effect (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Accrued Obligations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  In addition, subject to Sections 3(c), 3(g) and 4 below, if the Participant has a Qualifying Termination, the Participant shall be entitled to receive&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">Severance pay in an amount equal to the sum of (A) the Severance Multiple times the sum of the Base Amount and the Target Bonus and (B) a pro rata portion of the Participant&#8217;s Target Bonus for the partial fiscal year in which the Qualifying Termination occurs (prorated based on the number of days in the fiscal year in which the Qualifying Termination occurs through the termination date), payable in cash in a lump sum on the sixtieth (60th) day following the date of such Qualifying Termination&#894;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">During the period commencing on the effective date of the Qualifying Termination and ending on the earlier of (A) the eighteen (18)-month anniversary thereof, or (B) the date on which the Participant ceases to be eligible for COBRA continuation coverage (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">COBRA Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), subject to the Participant&#8217;s valid election to continue healthcare coverage under Code Section 4980B, the Company shall continue to provide the Participant and the Participant&#8217;s eligible dependents with coverage under its group health plans at the same levels and the same cost to the Participant as would have applied if the Participant&#8217;s employment had not been terminated based on the Participant&#8217;s elections in effect on the termination date, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, that (x) if any plan pursuant to which such benefits are provided is not, or ceases prior to the expiration of the period of continuation coverage to be, exempt from the application of Code Section 409A under Treasury Regulation Section 1.409A-1(a)(5), or (y) the Company is otherwise unable to continue to cover the Participant under its group health plans without incurring penalties (including without limitation, pursuant to Section 2716 of the Public Health Service Act), then, in either case, an amount equal to each remaining Company-paid portion of the premium under such plans shall thereafter be paid to the Participant in substantially equal monthly installments over the continuation coverage period (or the remaining portion thereof)&#894;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">For a period of up to twelve (12) months following the date of termination, the Participant shall be provided, at the Company&#8217;s expense, with outplacement services selected by the Company consistent with industry practice&#894; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.69pt">To the extent a Qualified Termination occurs and the Participant has not yet received his or her short term annual cash bonus for his or her prior year performance with the Company, the Participant shall still receive such short term annual cash bonus for prior year performance at the time non-terminated employees receive such short term annual cash bonus if such payment is due.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Change in Control&#894; Other Terminations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a Change in Control and&#47;or any termination of employment of the Participant, all outstanding unvested equity </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 4 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">or equity-based awards granted under any equity compensation plans of the Company shall be treated in accordance with the terms and conditions set forth in the applicable equity award agreement and equity compensation plan.  In addition, upon the Participant&#8217;s termination of employment for any reason other than a Qualifying Termination, the Company shall not have any other or further obligations to the Participant under this Program (including any financial obligations), except that the Participant shall be entitled to receive the Accrued Obligations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  As a condition to the Participant&#8217;s receipt of any amounts set forth in Section 3(a)(i) - (iv) above, the Participant shall execute and not revoke a general release of all claims in favor of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in the form substantially similar to the form attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%"> (and any statutorily prescribed revocation period applicable to such Release shall have expired) within the sixty (60) day period following the date of the Participant&#8217;s Qualifying Termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Exclusive Remedy&#894; Other Arrangements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of the Participant&#8217;s rights to salary, severance, benefits, bonuses and other amounts (if any) accruing after the termination of the Participant&#8217;s employment shall cease upon such termination.  The severance payments and benefits provided for in Section 3(a)(i) - (iv) above are not intended to duplicate any severance payments and&#47;or benefits that the Participant is or may become entitled to receive under any other plan, program, policy or agreement with the Company or any of its affiliates (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Arrangements</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Therefore, in the event that the Participant becomes entitled to receive the severance payments and benefits provided under Section 3(a)(i) - (iv) of this Program, the Participant shall receive the amounts provided under Section 3(a)(i) - (iv) of this Program and shall not be entitled to receive any severance payments or benefits pursuant to any Other Arrangements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">No Mitigation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant shall not be required to mitigate the amount of any payment provided for in this Section 3 by seeking other employment or otherwise, nor shall the amount of any payment or benefit provided for in this Section 3 be reduced by any compensation earned by the Participant as the result of employment by another employer or self-employment or by retirement benefits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt;text-decoration:underline">Return of the Company&#8217;s Property</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Participant&#8217;s employment is terminated for any reason, the Company shall have the right, at its option, to require the Participant to vacate the Participant&#8217;s offices prior to or on the effective date of termination and to cease all activities on the Company&#8217;s behalf.  Upon the termination of the Participant&#8217;s employment in any manner, as a condition to the Participant&#8217;s receipt of any post-termination benefits described in this Program, the Participant shall immediately surrender to the Company all lists, books and records of, or in connection with, the Company&#8217;s business, and all other property belonging to the Company, it being distinctly understood that all such lists, books and records, and other documents, are the property of the Company.  Upon the Company&#8217;s request, the Participant shall deliver to the Company a signed statement certifying compliance with this Section 3(f) prior to the receipt of any post-termination benefits described in this Program.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Parachute Payments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">It is the objective of this Program to maximize the Participant&#8217;s Net After-Tax Benefit (as defined herein) if payments or benefits provided under this Program are subject to excise tax under Code Section 4999.  Notwithstanding any other provisions of this Program, in the event that any payment or benefit by the Company or otherwise to or for the benefit of the Participant, whether paid or payable or distributed or distributable pursuant to the terms of this Program or otherwise (all such payments and benefits, including the payments and benefits under Section 3(a) or 3(b) above, being hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Total Payments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 5 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">would be subject (in whole or in part) to the excise tax imposed by Code Section 4999 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the payments and benefits shall thereafter be reduced in accordance with Section 3(g)(ii) below, to the extent necessary so that no portion of the Total Payments shall be subject to the Excise Tax, but only if (A) the net amount of such Total Payments, as so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total Payments), is greater than or equal to (B) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which the Participant would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total Payments).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">To the extent required under Section 3(g)(i) above, the Total Payments shall be reduced by the Company in the following order&#58; (A) reduction of any cash severance payments otherwise payable to the Participant that are exempt from Code Section 409A, (B) reduction of any other cash payments or benefits otherwise payable to the Participant that are exempt from Code Section 409A, but excluding any payments attributable to the acceleration of vesting or payments with respect to any equity award with respect to the Company&#8217;s common stock that is exempt from Code Section 409A, (C) reduction of any other payments or benefits otherwise payable to the Participant on a pro-rata basis or such other manner that complies with Code Section 409A, but excluding any payments attributable to the acceleration of vesting and payments with respect to any equity award with respect to the Company&#8217;s common stock that are exempt from Code Section 409A and (D) reduction of any payments attributable to the acceleration of vesting or payments with respect to any other equity award with respect to the Company&#8217;s common stock that are exempt from Code Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">All determinations regarding the application of this Section 3(g) shall be made by an accounting firm with experience in performing calculations regarding the applicability of Code Section 280G and the Excise Tax selected by the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Independent Advisors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  For purposes of determining whether and the extent to which the Total Payments will be subject to the Excise Tax, (A) no portion of the Total Payments the receipt or enjoyment of which the Participant shall have waived at such time and in such manner as not to constitute a &#8220;payment&#8221; within the meaning of Code Section 280G(b) shall be taken into account, (B) no portion of the Total Payments shall be taken into account which, in the opinion of the Independent Advisors, does not constitute a &#8220;parachute payment&#8221; within the meaning of Code Section 280G(b)(2) (including by reason of Code Section 280G(b)(4)(A)) and in calculating the Excise Tax, no portion of such Total Payments shall be taken into account which, in the opinion of Independent Advisors, constitutes reasonable compensation for services actually rendered, within the meaning of Code Section 280G(b)(4)(B), in excess of the &#8220;base amount&#8221; (as defined in Section Code 280G(b)(3)) allocable to such reasonable compensation and (C) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the Independent Advisors in accordance with the principles of Code Sections 280G(d)(3) and (4).  The costs of obtaining such determination and all related fees and expenses (including related fees and expenses incurred in any later audit) shall be borne by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  All compensation and benefits to the Participant hereunder shall be reduced by all federal, state, local and other withholdings and similar taxes and payments required by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Confidentiality, Restrictive Covenants and Proprietary Rights</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant acknowledges that during the course of performing services for the Company, the Participant shall have substantial access to trade secrets and other confidential information of the Company and its subsidiaries.  In consideration of and in connection with the participation in this Program, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 6 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">each Participant shall be subject to the Confidentiality, Invention Disclosure and Non-Compete terms set forth in this Section 4 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) in part to restrict the disclosure by the Participant of such trade secrets and other confidential information.  The Company shall be entitled to cease all severance payments and benefits to the Participant in the event of the Participant&#8217;s breach of the Restrictive Covenants and&#47;or any non-competition, non-solicitation, non-disparagement, confidentiality, or assignment of inventions covenants contained in any agreement between the Participant and the Company, which covenants are hereby incorporated by reference into this Program.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant shall not directly or indirectly use or disclose any technical data, trade secrets, know-how, research, product or business plans, formulae, processes, products, services, projects, proposals, customer lists and customers (including, but not limited to, customers of the Company on whom the Participant calls or with whom the Participant becomes acquainted during the term of the Participant&#8217;s employment), markets, software, developments, Inventions (as defined in Section 4(b) below), processes, formulas, technology, designs, drawings, engineering, marketing, distribution and sales methods and systems, sales and profit figures, finances and other business information created by the Participant during employment with the Company or disclosed to the Participant by the Company, either directly or indirectly in writing, orally or by drawings or inspection of documents or other tangible property (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), for the benefit of anyone other than the Company, either during or after the term of the Participant&#8217;s employment with the Company, without written authorization of the President and CEO of the Company or his designee.  The Participant shall return to the Company all such Confidential Information in his or her possession upon the termination of employment.  For the avoidance of doubt, nothing in this Program limits, restricts or in any other way affects any Participant&#8217;s communicating with any governmental agency or entity concerning matters relevant to the governmental agency or entity. No confidentiality or other obligation owed the Company prohibits any Participant from reporting possible violations of U.S. Federal law or regulation to any governmental agency or entity under any whistleblower protection provision of U.S. Federal or U.S. State law or regulation (including Section 21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002) or requires any Participant to notify the Company of any such report. In making any such report, however, the Participant is not authorized to disclose communications with counsel that were made for the purpose of receiving legal advice, that contain legal advice or that are protected by the attorney work product or similar privilege.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt;text-decoration:underline">Inventions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant shall promptly make full written disclosure to the Company (or any persons designated by it), shall hold in trust for the sole right and benefit of the Company, and hereby assigns to the Company, or its designee, without further compensation, all right, title, and interest in and to any and all inventions, original works of authorship, discoveries, design improvements, processes, trade secrets, trade know-how and all other intellectual property, whether or not patentable or registrable under patent, copyright or similar laws, and any and all rights and benefits resulting therefrom, that (i) relate to the business of the Company or any other company or person with which the Company is doing business or that relate to experimental work that the Company is doing or (ii) result from the use of the premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Inventions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which the Participant may solely or jointly conceive of, develop or reduce to practice during the period of time from the date of participation in this Program until the Participant&#8217;s employment with the Company is terminated.  All such Inventions and the benefits thereof shall immediately become the sole and absolute property of the Company and its assigns.  All original works of authorship which are made by the Participant (solely or jointly with others) within the scope of the Participant&#8217;s employment and which are protectable by copyright are &#8220;works made for hire,&#8221; as that term is defined in the United States Copyright Act.  To the extent that the Participant has not done so previously, and in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 7 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">consideration of the Participant&#8217;s continued employment with the Company, the Participant hereby assigns to the Company any and all Inventions which were made by the Participant during employment with Company up to the effective date of this Program (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Prior Inventions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  The Participant assigns all right, title and interest in and to all Prior Inventions to the Company and shall execute any and all documents necessary to affect such assignment.  The Participant shall assist Company, at Company&#8217;s sole expense, to obtain patents, copyrights or trademarks, as the case may be, on all such Inventions deemed patentable, copyrightable or trademarkable by Company and shall execute all documents and do all things necessary to obtain letters patent, copyrights and trademarks, vest in the Company full and exclusive title thereto, and protect the same against infringement by others.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Non-Competition&#894; Non-Solicitation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The Participant shall not, during the Participant&#8217;s employment at the Company and for a period of one year immediately following the termination of the Participant&#8217;s employment with the Company for any reason (whether voluntarily or involuntarily), either directly or indirectly, on the Participant&#8217;s behalf or in the service or on behalf of others&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.69pt">whether alone or as a partner, officer, director, consultant, agent, employee, contractor, or stockholder of any company or other commercial enterprise, directly or indirectly engage in any business or other activity conducted or operated in the United States, Canada and internationally which is or may be competitive with, or render services to any firm or business organization which competes or which plans to compete with, the Company in the products or services being published, manufactured, marketed, distributed, planned in writing or developed by the Company at the time of termination of such employment&#894;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.36pt">entice or induce any customer, vendor, distributor, OEM manufacturer or employee of the Company to become a client, customer, OEM, distributor or reseller of any other person, firm or corporation with respect to products and&#47;or services then sold or under development by the Company or competitive with products and&#47;or services then sold or under development by the Company, or to cease doing business with the Company, and shall not contact or approach any such person, firm or corporation for such purpose or authorize or knowingly approve the taking of such actions by any other person&#894; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.03pt">solicit, recruit or hire (or attempt to solicit, recruit or hire) any employee of the Company (whether or not such person is a full-time employee or whether or not such employment is pursuant to a written agreement or at-will) to terminate such person&#8217;s employment with the Company, work for a third party other than the Company, work in self-employment or as an independent contractor, or engage in any activity that would cause any such employee to violate any agreement with the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall be deemed to compete in the United States, Canada and internationally in those segments of the medical devices industry in which the Company shall be engaged in business during the Participant&#8217;s employment with the Company and as of the date of termination of this Program, and the Participant shall not engage in any of the activities proscribed in this Section 4(c) in such segments in the United States, Canada and internationally for the time periods set forth in this Section 4(c).  If the Participant violates or is in breach of any provision of this Section 4(c), then the provisions of this Section 4(c) shall be applicable to him for an additional period of one year after the date of such violation or breach.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">At-Will Employment Relationship</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as may be expressly provided in an applicable Other Arrangement, the Participant&#8217;s employment with the Company is at-will and not for any specified period and may be terminated at any time, with or without Cause or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 8 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">advance notice, by either the Participant or the Company.  Any change to the at-will employment relationship must be by specific, written agreement signed by the Participant and an authorized representative of the Company.  Nothing in this Program is intended to or should be construed to contradict, modify or alter this at-will relationship.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Program Administration</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The Program shall be interpreted, administered and operated by the Committee, which shall have the complete authority, in its sole discretion, subject to the express provisions of the Program, to interpret the Program, adopt any rules and regulations for carrying out the Program as may be appropriate and decide any and all matters and make any and all determinations arising under or otherwise necessary or advisable for the administration of the Program. All interpretations and decisions by the Committee shall be final, conclusive and binding on all parties affected thereby. Notwithstanding the foregoing, the Committee shall have the right to delegate to any individual member of the Committee or to any executive of the Company any of the Committee&#8217;s authority under the Program&#894; provided, that no person shall act as Program administrator in any matter directly relating to his or her eligibility or amount of severance and&#47;or benefits under the Program. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The rights of the Company under this Program may, without the consent of the Participant, be assigned by the Company, in its sole and unfettered discretion, to any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of the Company.  Any successor (whether direct or indirect, by purchase, merger or otherwise) to all or substantially all of the business or assets of the Company shall assume and perform this Program in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.  As used in this Program, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; shall mean the Company as hereinbefore defined and any successor to its business and&#47;or assets as aforesaid which assumes and agrees to perform this Program by operation of law or otherwise.  The Participant shall not be entitled to assign any of the Participant&#8217;s rights or obligations under this Program.  This Program shall inure to the benefit of and be enforceable by the Participant&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event any provision of this Program is found to be unenforceable by an arbitrator or court of competent jurisdiction, such provision shall be deemed modified to the extent necessary to allow enforceability of the provision as so limited, it being intended that the parties shall receive the benefit contemplated herein to the fullest extent permitted by law.  If a deemed modification is not satisfactory in the judgment of such arbitrator or court, the unenforceable provision shall be deemed deleted, and the validity and enforceability of the remaining provisions shall not be affected thereby.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.4</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Interpretation&#894; Construction</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The headings set forth in this Program are for convenience only and shall not be used in interpreting this Program.  Either party&#8217;s failure to enforce any provision of this Program shall not in any way be construed as a waiver of any such provision or prevent that party thereafter from enforcing each and every other provision of this Program.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  This Program will be governed by and construed in accordance with the laws of the United States and the State of New Jersey applicable to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 9 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.6</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Arbitration and Equitable Relief</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in the last two sentences of this paragraph, any dispute or controversy arising out of this Program, or relating to any interpretation, construction, performance or breach of this Program, shall be settled by an expedited arbitration to be held in Middlesex County, New Jersey, in accordance with the National Rules of the American Arbitration Association (then in effect) governing employment disputes, subject to the provisions of this Section 6.6.  The arbitration proceeding and all filing, testimony, documents and information relating to or presented during the arbitration proceeding shall be disclosed exclusively for the purpose of facilitating the arbitration process and for no other purpose and shall be deemed to be information subject to the confidentiality provisions of this Program.  The arbitrator may grant injunctions or other relief in such dispute or controversy.  The decision of the arbitrator shall be final, conclusive and binding on the parties to the arbitration.  Judgment may be entered on the arbitrator&#8217;s decision in any court having jurisdiction.  The Participant acknowledges that it would be impossible or inadequate to fully measure and calculate the Company&#8217;s damages from any breach of the covenants set forth in Section 4 of this Program.  Accordingly, in the event of a Participant&#8217;s breach any of such covenants, the Company will have available, in addition to any other right or remedy available, the right to obtain an injunction from a court of competent jurisdiction restraining such breach or threatened breach and to specific performance of any such provision of this Program.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.7</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Any notice required or permitted by this Program shall be in writing and shall be delivered as follows with notice deemed given as indicated&#58; (a) by personal delivery when delivered personally&#894; (b) by overnight courier upon written verification of receipt&#894; (c) by e-mail, telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission&#894; or (d) by certified or registered mail, return receipt requested, upon verification of receipt.  Notice shall be sent to the Participant at the Participant&#8217;s most recent address on the records of the Company and to the Company at its principal place of business, or such other address as either party may specify in writing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Sections 1 (&#8220;Definitions&#8221;), 3 (&#8220;Obligations of the Company&#8221;), 4 (&#8220;Confidentiality, Restrictive Covenants and Proprietary Rights&#8221;), and 6 (&#8220;General Provisions&#8221;) of this Program shall survive termination of the Participant&#8217;s employment with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.9</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  This Program, the Restrictive Covenants and any other covenants and agreements incorporated herein by reference, as set forth in Section 4 above, together constitute the entire agreement between the parties in respect of the subject matter contained herein and therein and supersede all prior or simultaneous representations, discussions, negotiations, and agreements, whether written or oral, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, that for the avoidance of doubt, all Other Arrangements (as such Other Arrangements may be amended, modified or terminated from time to time) shall remain in effect in accordance with their terms, subject to Section 3(d) above.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.10</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">To the extent applicable, this Program shall be interpreted in accordance with Code Section 409A and Department of Treasury regulations and other interpretive guidance issued thereunder.  Notwithstanding any provision of this Program to the contrary, if the Company determines that any compensation or benefits payable under this Program may be subject to Code Section 409A, the Company may adopt such amendments to this Program or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Company determines are necessary or appropriate to avoid the imposition of taxes under Code Section 409A, including without limitation, actions intended to (i) exempt the compensation and benefits payable under this Program from Code Section 409A, and&#47;or (ii) comply with the requirements of Code Section 409A&#894; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, that this Section 6.10(a) shall not create any obligation on the part of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 10 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">the Company to adopt any such amendment, policy or procedure or take any such other action, nor shall the Company have any liability for failing to do so.  For purposes of Code Section 409A, each payment made under this Program shall be treated as a separate payment.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">If the Participant is a &#8220;specified employee&#8221; (as defined in Code Section 409A), as determined by the Company in accordance with Code Section 409A, on the date of the Participant&#8217;s Separation from Service, to the extent that the payments or benefits under this Program are subject to Code Section 409A and the delayed payment or distribution of all or any portion of such amounts to which the Participant is entitled under this Program is required in order to avoid a prohibited distribution under Code Section 409A(a)(2)(B)(i), then such portion delayed pursuant to this Section 6.10(b) shall be paid or distributed to the Participant in a lump sum on the earlier of (i) the date that is six (6)-months and one day following the Participant&#8217;s Separation from Service, (ii) the date of the Participant&#8217;s death or (iii) the earliest date as is permitted under Code Section 409A.  Any remaining payments due under this Program shall be paid as otherwise provided herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">To the extent that any payments or reimbursements provided to the Participant under this Program are deemed to constitute compensation to the Participant to which Treasury Regulation Section 1.409A-3(i)(1)(iv) would apply, such amounts shall be paid or reimbursed reasonably promptly, but not later than December 31 of the year following the year in which the expense was incurred.  The amount of any such payments eligible for reimbursement in one year shall not affect the amount of payments or expenses that are eligible for payment or reimbursement in any other taxable year, and the Participant&#8217;s right to such payments or reimbursement of any such expenses shall not be subject to liquidation or exchange for any other benefit.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.11</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Termination&#59; Amendment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The Committee may terminate or amend this Program at any time, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided that</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, in the event such termination or amendment is determined by the Committee to be material and adverse to a Participant, the Committee shall provide six (6) months&#8217; prior written notice to such Participant, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">provided further</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">, that the Committee may not amend the Program in a manner that is adverse to a Participant during the two (2) years following a Change in Control.  The Committee may, at any time, amend the Program in any manner it determines in good faith is necessary or appropriate to comply with applicable law, including as set forth in Section 6.10(a).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.12</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:15pt;text-decoration:underline">Source of Funds</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Amounts payable to the Participant under this Program shall be from the general funds of the Company.  The Participant&#8217;s rights to unpaid amounts under this Program shall be solely those of an unsecured creditor of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">- 11 -</font></div></div></div><div id="i723662e7209f48fb849a8f95edc18aeb_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT A<br><br></font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">AGREEMENT AND GENERAL RELEASE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement and General Release (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made and entered into by and between _________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Releasor</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Integra LifeSciences Corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">the Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company has decided to terminate Releasor&#8217;s employment relationship by way of Releasor&#8217;s involuntary termination from employment effective ____________&#894; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Releasor and the Company wish to enter into this Agreement which settles fully and finally any and all differences and matters between them.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">IT IS HEREBY AGREED by and between Releasor and the Company as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Releasor, for and in consideration of the Company&#8217;s undertakings set forth herein, and intending to be legally bound, does hereby REMISE, RELEASE, AND FOREVER DISCHARGE the Company and its parent, subsidiary and affiliated entities, its and their respective officers, directors, employees and agents, and its and their predecessors, successors and assigns, heirs, executors and administrators, of and from any and all manner of legally waivable actions and causes of action, suits, debts, claims and demands whatsoever, in law or in equity, which Releasor ever had, now has, or hereafter may have, or which Releasor&#8217;s heirs, executors or administrators hereafter may have, by reason of any matter, cause or thing whatsoever, from the beginning of the world to the effective date of this Agreement, and particularly, but without limitation of the foregoing general terms, any claims arising from or relating in any way to Releasor&#8217;s employment relationship and the termination of Releasor&#8217;s employment relationship with the Company, including any claims which Releasor may have under federal, state or local laws, rules and regulations, including but not limited to, the New Jersey Law Against Discrimination (NJSA 10&#58;5-1 et seq.)&#894; New Jersey Conscientious Employee Protection Act (NJSA 34&#58;19-1 et seq.)&#894; Title VII of the Civil Rights Act of 1964, 42 U.S.C. &#167;&#160;2000e et seq.&#894; the Equal Pay Act of 1963, 29 U.S.C. &#167;&#160;206 et seq., the Americans with Disabilities Act, 42 U.S.C. &#167;&#160;12101 et seq., the Family and Medical Leave Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">FMLA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the Age Discrimination in Employment Act (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), 29 U.S.C. &#167;&#160;621 et seq., the Employee Retirement Income Security Act of 1974, 29 U.S.C. &#167;&#160;1001 et seq., any state or federal common law contract or tort claims now existing or hereafter recognized, including but not limited to breach of contract, promissory estoppel, equitable estoppel, misrepresentation or wrongful discharge, and all claims for counsel fees and costs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">In full consideration of Releasor&#8217;s signing this Agreement, and Releasor&#8217;s agreement to be bound by its terms, the Company will&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">pay to Releasor the gross sum of __________________ ($__________), less all payroll withholding taxes and other deductions required by law, in a lump sum payment made on the sixtieth (60th) day following Releasor&#8217;s termination of employment, pursuant to the Company&#8217;s Change in Control Severance Program&#894;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">in response to inquiries from prospective employers, state only Releasor&#8217;s dates of employment, positions held and that the position was eliminated.  Releasor will direct all such inquiries to the Work Number at (866) 604-6572&#894;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Provide Releasor and Releasor&#8217;s eligible dependents with coverage under its group health plans at the same levels and the same cost to Releasor as would have applied if </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">A-1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">Releasor&#8217;s employment had not been terminated based on Releasor&#8217;s elections in effect on the termination date, in accordance with the terms and conditions set forth in the Company&#8217;s Change in Control Severance Program&#894; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">provide Releasor with outplacement services, as selected by the Company, for a period of _____ months, payment for which shall be paid by Company directly to the service provider.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">It is expressly agreed and understood that neither the Company nor its affiliated entities has, or will have, any obligation to provide Releasor at any time in the future with any payments, benefits or considerations other than those recited in Paragraph 2 above, except for any reasonable claims for vested benefits under the terms of any of the Company&#8217;s employee benefit plans.  In addition, notwithstanding anything to the contrary contained herein, this Agreement shall not operate to release any rights or claims of Releasor (i) to payments or benefits under Section 2 above, (ii) to payments or benefits under any equity award agreement between Releasor and the Company, (iii) to accrued or vested benefits Releasor may have, if any, as of the date hereof under any applicable plan, policy, practice, program, contract or agreement with the Company, (v) to any claims, including claims for indemnification and&#47;or advancement of expenses arising under any indemnification agreement between Releasor and the Company or under the bylaws, certificate of incorporation of other similar governing document of the Company or (vi) to any claims which cannot be waived by an employee under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Releasor agrees and acknowledges that the agreement by the Company described herein is not and shall not be construed to be an admission of any violation of any federal, state or local law, rule or regulation, or of any legal obligation or duty owed by the Company to Releasor and that this Agreement is made voluntarily to provide an amicable conclusion of Releasor&#8217;s employment relationship with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Releasor hereby agrees and acknowledges that Releasor&#8217;s employment relationship with the Company is being permanently and irrevocably severed and that the Company does not have any obligation, contractual or otherwise, to hire, rehire or re-employ Releasor in the future.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Releasor will cooperate in any reasonable manner even after leaving employment and will provide assistance to the Company in concluding any matters which may arise in the future which may relate to Releasor&#8217;s employment with the Company, provided that such cooperation and assistance shall not unreasonably interfere with any subsequent employment obtained by Releasor.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">The terms of the Confidentiality, Invention Disclosure and Non-Compete Agreement signed by Releasor on ________________, are incorporated herein by reference.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Releasor hereby certifies that Releasor has read the terms of the Agreement, that the Company hereby advises Releasor to consult with an attorney of Releasor&#8217;s own choice prior to executing this Agreement, that Releasor has had an opportunity to do so and that Releasor understands this Agreement&#8217;s terms and effects.  Releasor acknowledges, further, that Releasor is executing this Agreement of Releasor&#8217;s own volition, with full understanding of its terms and effects and with the intention of releasing all employment claims recited herein in exchange for the consideration described herein, which Releasor acknowledges is adequate and satisfactory.  Releasor certifies that neither the Company nor any of its agents, representatives, or attorneys has made any representations to Releasor concerning the terms or effects of this Agreement other than those contained herein.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">A-2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt">Releasor acknowledges that Releasor has been informed that Releasor has the right to consider this Agreement for a period of at least twenty-one (21) days prior to entering into the Agreement.  Releasor also understands that Releasor has the right to revoke this Agreement for a period of seven (7) days following Releasor&#8217;s execution of the Agreement by giving written notice to the Company, within said seven (7) day period, in care of the Corporate Vice President and Chief Human Resources Officer, or his or her successor in that capacity, at the following address&#58; Integra LifeSciences Corporation, 311 Enterprise Drive, Plainsboro, New Jersey 08536.  This Agreement shall be effective upon expiration of said seven (7) day period.  If Releasor exercises Releasor&#8217;s right to revoke this agreement, this Agreement shall be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Releasor further agrees, covenants and promises that Releasor will not communicate or disclose the terms of this Agreement, as described herein, to any persons with the exception of members of Releasor&#8217;s immediate family, Releasor&#8217;s attorney, and Releasor&#8217;s accountant, all of whom shall be advised of the confidentiality requirements of this Agreement and who must agree to be bound by this provision as a condition of such disclosure.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Releasor shall not engage in any communications that disparage the Company and&#47;or its directors, officers, or employees or interfere with its existing or prospective business relationships.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">Releasor represents that Releasor has returned all material and property in Releasor&#8217;s possession that belongs to the Company including, but not limited to keys and any other material or equipment belonging to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#010000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt">This Agreement, together with the Confidentiality, Invention Disclosure and Non-Compete Agreement signed on ____________, represents the entire agreement between the parties and may not be waived, modified or amended except by a writing executed by both parties.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">(Remainder of Page Left Intentionally Blank)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">A-3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, and intending to be legally bound hereby, the parties hereto have executed the foregoing Agreement. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.339%"><tr><td style="width:1.0%"></td><td style="width:9.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">INTEGRA LIFESCIENCES CORPORATION</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">DATE&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.500%"><tr><td style="width:1.0%"></td><td style="width:9.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.911%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">RELEASOR </font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">DATE&#58;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">A-4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>iart-20251211.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:019b0429-3cd9-7863-984f-7f8fca2cf9a4,g:a9d7697a-a4c4-4f6e-a467-2e81f3a981f3-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iart="http://integralife.com/20251211" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://integralife.com/20251211">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20251211_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20251211_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20251211_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://integralife.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>iart-20251211_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:019b0429-3cd9-7863-984f-7f8fca2cf9a4,g:a9d7697a-a4c4-4f6e-a467-2e81f3a981f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20251211.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_019b0429-3cd9-7297-9b06-3bf5a30fda59" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntitiesTable_019b0429-3cd9-7297-9b06-3bf5a30fda59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_019b0429-3cd9-7e50-a05f-8bdbf0033686" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_019b0429-3cd9-7297-9b06-3bf5a30fda59" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_019b0429-3cd9-7e50-a05f-8bdbf0033686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_019b0429-3cd9-7e50-a05f-8bdbf0033686_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_019b0429-3cd9-7e50-a05f-8bdbf0033686" xlink:to="loc_dei_AddressTypeDomain_019b0429-3cd9-7e50-a05f-8bdbf0033686_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_019b0429-3cd9-7772-b9ae-87ba3ce73f2d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_019b0429-3cd9-7e50-a05f-8bdbf0033686" xlink:to="loc_dei_AddressTypeDomain_019b0429-3cd9-7772-b9ae-87ba3ce73f2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019b0429-3cd9-7f9c-9d94-66cbeefa07ec" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_DocumentType_019b0429-3cd9-7f9c-9d94-66cbeefa07ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019b0429-3cd9-7a35-95ce-950d92193efc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_DocumentPeriodEndDate_019b0429-3cd9-7a35-95ce-950d92193efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019b0429-3cd9-7ba7-a1d6-1f7955509941" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityRegistrantName_019b0429-3cd9-7ba7-a1d6-1f7955509941" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019b0429-3cd9-7f2f-af84-df2fb6a9e911" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019b0429-3cd9-7f2f-af84-df2fb6a9e911" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019b0429-3cd9-74bf-b420-194172e16cb3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityFileNumber_019b0429-3cd9-74bf-b420-194172e16cb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019b0429-3cd9-7d88-a636-dbbaa582419f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityTaxIdentificationNumber_019b0429-3cd9-7d88-a636-dbbaa582419f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019b0429-3cd9-7834-8c1f-023dcb95230f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityAddressAddressLine1_019b0429-3cd9-7834-8c1f-023dcb95230f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019b0429-3cd9-7ec4-bbd5-45f447c3fc2a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityAddressCityOrTown_019b0429-3cd9-7ec4-bbd5-45f447c3fc2a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019b0429-3cd9-71af-80d6-b8638f2e98de" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityAddressStateOrProvince_019b0429-3cd9-71af-80d6-b8638f2e98de" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019b0429-3cd9-7f61-a5a1-859ad8144ea7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityAddressPostalZipCode_019b0429-3cd9-7f61-a5a1-859ad8144ea7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019b0429-3cd9-77a4-9537-a117bb0020ef" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_CityAreaCode_019b0429-3cd9-77a4-9537-a117bb0020ef" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019b0429-3cd9-79cb-8b3e-b971b3e32b32" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_LocalPhoneNumber_019b0429-3cd9-79cb-8b3e-b971b3e32b32" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019b0429-3cd9-763e-83c9-a456e56422d1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_WrittenCommunications_019b0429-3cd9-763e-83c9-a456e56422d1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019b0429-3cd9-76cb-9fe0-0c0d2b0f90d9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_SolicitingMaterial_019b0429-3cd9-76cb-9fe0-0c0d2b0f90d9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019b0429-3cd9-78a0-bf79-0b0ecd697a18" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_PreCommencementTenderOffer_019b0429-3cd9-78a0-bf79-0b0ecd697a18" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019b0429-3cd9-736f-82dc-956907d086ca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019b0429-3cd9-736f-82dc-956907d086ca" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019b0429-3cd9-7f2d-a840-94ebc6f0c88a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_Security12bTitle_019b0429-3cd9-7f2d-a840-94ebc6f0c88a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019b0429-3cd9-7c1f-bcb4-317df5f6340f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_TradingSymbol_019b0429-3cd9-7c1f-bcb4-317df5f6340f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019b0429-3cd9-7d5c-9e6f-252bf6ee7c83" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_SecurityExchangeName_019b0429-3cd9-7d5c-9e6f-252bf6ee7c83" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019b0429-3cd9-7db4-91dc-001f3069d247" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityEmergingGrowthCompany_019b0429-3cd9-7db4-91dc-001f3069d247" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019b0429-3cd9-73d4-915e-f26be7c29c71" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityCentralIndexKey_019b0429-3cd9-73d4-915e-f26be7c29c71" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019b0429-3cd9-7e7c-90f2-8dac9b5456eb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_AmendmentFlag_019b0429-3cd9-7e7c-90f2-8dac9b5456eb" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>iart-20251211_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:019b0429-3cd9-7863-984f-7f8fca2cf9a4,g:a9d7697a-a4c4-4f6e-a467-2e81f3a981f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_019b0429-3cd9-76ef-bbce-5f63ab356ad6_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019b0429-3cd9-733e-9d4f-20476c25bf5c_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019b0429-3cd9-796b-80c6-895ebd9e5096_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_019b0429-3cd9-76e5-aad4-13e0c7836855_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019b0429-3cd9-7a3b-b3f1-1a71d874b46e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019b0429-3cd9-7fc8-9084-e2ca26cf50f5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019b0429-3cd9-7173-ad2b-55ecb29e4aab_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019b0429-3cd9-7cb5-8d6c-03bde877b0b1_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019b0429-3cd9-7856-b1b8-f6a884923ace_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019b0429-3cd9-7897-999d-6cd3e68f752d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019b0429-3cd9-79cc-9edf-f25eac5cfab5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_019b0429-3cd9-7b73-aad5-365c99b9d019_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_019b0429-3cd9-780b-9ba0-68c9a3236a6c_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019b0429-3cd9-7812-8502-585ef9300363_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019b0429-3cd9-7dfe-96de-231377bc0066_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019b0429-3cd9-7577-8d34-69e55f1bab3c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019b0429-3cd9-779f-89ba-f34adb5d9923_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019b0429-3cd9-749c-b7f6-bf485a0e9e3c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_019b0429-3cd9-7e13-8ce2-345bf2dc3a62_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_019b0429-3cd9-7024-9dc2-f91e117d69b2_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019b0429-3cd9-722d-a138-1cd1293171fb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019b0429-3cd9-776e-9e67-e976bc381698_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019b0429-3cd9-7128-a57d-331f2241f1cb_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019b0429-3cd9-7c3a-828a-d7f900905a67_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019b0429-3cd9-7042-bbbe-485981977479_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019b0429-3cd9-754d-a6d8-c9f1e924dd52_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019b0429-3cd9-7d0a-ab55-68eca7e83325_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>iart-20251211_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:019b0429-3cd9-7863-984f-7f8fca2cf9a4,g:a9d7697a-a4c4-4f6e-a467-2e81f3a981f3-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20251211.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019b0429-3cd9-70e7-9368-ed31f5c5416d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_019b0429-3cd9-7297-9b06-3bf5a30fda59" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019b0429-3cd9-70e7-9368-ed31f5c5416d" xlink:to="loc_dei_EntitiesTable_019b0429-3cd9-7297-9b06-3bf5a30fda59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_019b0429-3cd9-7e50-a05f-8bdbf0033686" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_019b0429-3cd9-7297-9b06-3bf5a30fda59" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_019b0429-3cd9-7e50-a05f-8bdbf0033686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_019b0429-3cd9-7772-b9ae-87ba3ce73f2d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_019b0429-3cd9-7e50-a05f-8bdbf0033686" xlink:to="loc_dei_AddressTypeDomain_019b0429-3cd9-7772-b9ae-87ba3ce73f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_019b0429-3cd9-7297-9b06-3bf5a30fda59" xlink:to="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019b0429-3cd9-7f9c-9d94-66cbeefa07ec" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_DocumentType_019b0429-3cd9-7f9c-9d94-66cbeefa07ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019b0429-3cd9-7a35-95ce-950d92193efc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_DocumentPeriodEndDate_019b0429-3cd9-7a35-95ce-950d92193efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019b0429-3cd9-7ba7-a1d6-1f7955509941" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityRegistrantName_019b0429-3cd9-7ba7-a1d6-1f7955509941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019b0429-3cd9-7f2f-af84-df2fb6a9e911" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019b0429-3cd9-7f2f-af84-df2fb6a9e911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019b0429-3cd9-74bf-b420-194172e16cb3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityFileNumber_019b0429-3cd9-74bf-b420-194172e16cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019b0429-3cd9-7d88-a636-dbbaa582419f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityTaxIdentificationNumber_019b0429-3cd9-7d88-a636-dbbaa582419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019b0429-3cd9-7834-8c1f-023dcb95230f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityAddressAddressLine1_019b0429-3cd9-7834-8c1f-023dcb95230f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019b0429-3cd9-7ec4-bbd5-45f447c3fc2a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityAddressCityOrTown_019b0429-3cd9-7ec4-bbd5-45f447c3fc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019b0429-3cd9-71af-80d6-b8638f2e98de" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityAddressStateOrProvince_019b0429-3cd9-71af-80d6-b8638f2e98de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019b0429-3cd9-7f61-a5a1-859ad8144ea7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityAddressPostalZipCode_019b0429-3cd9-7f61-a5a1-859ad8144ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019b0429-3cd9-77a4-9537-a117bb0020ef" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_CityAreaCode_019b0429-3cd9-77a4-9537-a117bb0020ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019b0429-3cd9-79cb-8b3e-b971b3e32b32" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_LocalPhoneNumber_019b0429-3cd9-79cb-8b3e-b971b3e32b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019b0429-3cd9-763e-83c9-a456e56422d1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_WrittenCommunications_019b0429-3cd9-763e-83c9-a456e56422d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019b0429-3cd9-76cb-9fe0-0c0d2b0f90d9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_SolicitingMaterial_019b0429-3cd9-76cb-9fe0-0c0d2b0f90d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019b0429-3cd9-78a0-bf79-0b0ecd697a18" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_PreCommencementTenderOffer_019b0429-3cd9-78a0-bf79-0b0ecd697a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019b0429-3cd9-736f-82dc-956907d086ca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019b0429-3cd9-736f-82dc-956907d086ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019b0429-3cd9-7f2d-a840-94ebc6f0c88a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_Security12bTitle_019b0429-3cd9-7f2d-a840-94ebc6f0c88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019b0429-3cd9-7c1f-bcb4-317df5f6340f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_TradingSymbol_019b0429-3cd9-7c1f-bcb4-317df5f6340f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019b0429-3cd9-7d5c-9e6f-252bf6ee7c83" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_SecurityExchangeName_019b0429-3cd9-7d5c-9e6f-252bf6ee7c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019b0429-3cd9-7db4-91dc-001f3069d247" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityEmergingGrowthCompany_019b0429-3cd9-7db4-91dc-001f3069d247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019b0429-3cd9-73d4-915e-f26be7c29c71" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_EntityCentralIndexKey_019b0429-3cd9-73d4-915e-f26be7c29c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019b0429-3cd9-7e7c-90f2-8dac9b5456eb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_019b0429-3cd9-787b-8ee2-31be16cbbdc2" xlink:to="loc_dei_AmendmentFlag_019b0429-3cd9-7e7c-90f2-8dac9b5456eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 11,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTEGRA LIFESCIENCES HOLDINGS CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0317849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1100 Campus Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">275-0500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $.01 Per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IART<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000917520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="iart-20251211.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="iart-20251211.htm">iart-20251211.htm</File>
    <File>iart-20251211.xsd</File>
    <File>iart-20251211_def.xml</File>
    <File>iart-20251211_lab.xml</File>
    <File>iart-20251211_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "iart-20251211.htm": {
   "nsprefix": "iart",
   "nsuri": "http://integralife.com/20251211",
   "dts": {
    "inline": {
     "local": [
      "iart-20251211.htm"
     ]
    },
    "schema": {
     "local": [
      "iart-20251211.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "iart-20251211_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "iart-20251211_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iart-20251211_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 27,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://integralife.com/role/DocumentandEntityInformation",
     "longName": "0000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iart-20251211.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "iart-20251211.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type [Axis]",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000917520-25-000100-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000917520-25-000100-xbrl.zip
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M&I7?($/2<6Z?C+ 3I+"&N^Y'7LR5/,3TMB2+G>>LOZ&']I32W%1NRP[0+J)
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M]=JK"#P^!GRB^63$@5/455"E'X*=D]V])6R A=CM.5[3)JS]*,$A$^H^HI>
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MIU)-:R6%<50!F7+;!(]2-)T)9E9SCC+_J(-Z_:RU5]N953!2+JX#G-H?_U]
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M(X]I$:V2H+Q#*65I&F.8KN0U^']N-BKL7.U2]_*7]5SJZ^:X%A!CA/_/8QN
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M&1.1LW1S/XUZ?U> *"1Q&D&2!DF('8ZX:1?M49JFFPIQT%:WW/K55R_=[GJ
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M9C4]K/,H 7"K#@Y>)#B7@G20-7;9;L0(.?:,T5K5 [.Q7F\YLK?]5E0@*FF
M(NLS@&(X!M&*AN?6#ITCVD=.=R#CD83_!DRJ[8I;OK8/@ML#8'Z(:"C 'K"D
MQ*,^J&XXV#![X(3P_P"QO[!',6G<PB1U"^Z\?,]F-?\YBQ'S9(0\%=,P##&E
M@=?!=+%IM1$7?D^X:"WK46!QE0MMYMI4HGRTP8"QOL]+LQQK6<]_1"&FD@!)
M>\8C1H%Z75#R4R<:01/T"IKN1#\*AMZF&;R_GW$PV[X'7"$>$(P\RWU,*FG\
M#H#Y8;$1'6&OZ-A3SJ- X8XMKJ05+E7I4QUU]T!DDB 6^1&2G#,6)B3PJ.J
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M-]LBUJ^*9WN5CP*6L=7/L.S*+HL6_T!M +YT P@!*1)QBSJA(NYB$]"6V6:
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M,#(U,3(Q,5]D968N>&UL4$L! A0#%     @ YH.,6VP2UG2)"@  .V,  !4
M             ( !.&0  &EA<G0M,C R-3$R,3%?;&%B+GAM;%!+ 0(4 Q0
M   ( .:#C%NVR6\:B@8  (HZ   5              "  ?1N  !I87)T+3(P
D,C4Q,C$Q7W!R92YX;6Q02P4&      8 !@"+ 0  L74

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>iart-20251211_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="iart-20251211.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2025-12-11</startDate>
            <endDate>2025-12-11</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000917520</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-12-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">INTEGRA LIFESCIENCES HOLDINGS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">0-26224</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">51-0317849</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1100 Campus Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">275-0500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, Par Value $.01 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">IART</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
